Screening of active ingredients of herbal medicine for interaction with CYP450 3A4

Phytotherapy Research

Volumn 21, Issue 11, 2007, Pages 1096-1099

  Lee, S S ^a   Zhang, B ^b   He, M L ^b   Chang, V S C ^c   Kung, H F ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Herbcopoeia Pharmaceutical Inc   (Taiwan)

Author keywords

CYP450; Herbal screening; HIV

Indexed keywords

CYTOCHROME P450 3A4; GINSENG EXTRACT; HERBACEOUS AGENT; LONICERA JAPONICA EXTRACT; PRUNELLA VULGARIS EXTRACT; RICINUS COMMUNIS EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SOPHORA FLAVESCENS EXTRACT; TRICHOSANTHES EXTRACT; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; DRUG IDENTIFICATION; HERBAL MEDICINE; HIGH THROUGHPUT SCREENING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONICERA JAPONICA; MEDICINAL PLANT; PANAX NOTOGINSENG; PRUNELLA VULGARIS; RICINUS COMMUNIS; SCUTELLARIA BAICALENSIS; SOPHORA FLAVESCENS; TRICHOSANTHES KIRILOWII;

ADJUVANTS, PHARMACEUTIC; ALGORITHMS; CYTOCHROME P-450 ENZYME SYSTEM; DRUGS, CHINESE HERBAL; HIV PROTEASE INHIBITORS; MEDICINE, CHINESE TRADITIONAL; PLANTS, MEDICINAL;

SOPHORA FLAVESCENS;

EID: 36549063434     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2149     Document Type: Article

References (6)

1. Ameer B, Weintraub RA. 1997. Drug interactions with grapefruit juice. Clin Pharmacokinet 33: 103-121.
2. Bailey DG, Malcolm J, Arnold O, Spence JD. 1998. Grapefruit juice - drug interactions. Br J Clin Pharmacol 46: 101-110.
3. Delgoda R, Westlake ACG. 2004. Herbal interactions involving cytochrome P450 enzymes - a mini review. Toxicol Rev 23: 239-249.
4. Gazzard B, on behalf of the BHIVA Writing Committee. 2006. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med 7: 487-503.
5. Kupferschmidt HHT, Fattinger KE, Ha HR, Follath R, Krähenbühl S. 1998. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 45: 355-359.
6. Stressor DM, Blanchard AP, Turner SD et al. 2000. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28: 1440-1448.